Page 144 - Read Online
P. 144

Tsutsui et al. Hepatoma Res 2018;4:13  I  http://dx.doi.org/10.20517/2394-5079.2018.20                                              Page 5 of 11


               Table 1. Patient characteristics, baseline liver function, and tumor characteristics: treatment group versus control group
                                                         Treatment group       Control group
                Variables                                   (n = 13)             (n = 36)          P
                Age (years)*                              69 (50-81)           74 (50-78)         0.128
                Gender (male/female)                      10/3                 29/7               1.000
                Etiology
                  Hepatitis B carrier                     1                    6                  0.298
                  Hepatitis C carrier                     11                   22
                  Others                                  1                    8
                Cirrhotic liver                           10                   16                 0.054
                Child-Pugh score at time of hepatectomy*  5.0 (5.0-6.0)        5.0 (5.0-6.0)      0.481
                AFP level (ng/mL)*                        6.6 (2.0-3921.0)     14.3 (2.0-2720.0)  0.504
                DCP level (ng/mL)*                        130 (13-3252)        74 (1.0-5940)      0.548
                Tumor diameter (mm)*                      27.0 (14.0-50.0)     25.0 (10.0-58.0)   0.666
                Tumor number*                             1 (1-2)              1 (1-3)            0.708
                Presence of portal vein tumor thrombosis (Vp2-4)  0            0                  1.000
                Presence of satellite nodules             6                    12                 0.411
                TNM pathological staging (stage I/II/IIIA/IIIB/IIIC/IV)  3/10/0/0/0/0  15/19/2/0/0/0  0.278
               *Median with range. AFP: alpha-fetoprotein; DCP: des-gamma-carboxyprothrombin; TNM: tumor nodes metastasis [6th edition of the
               American Joint Committee on Cancer (AJCC) staging]

               Table 2. Outcomes of temporary indwelling catheter system implantation: treatment group
                Variables                                                         n
                Puncture region                                                 13/0/0
                (left brachial artery/right femoral artery/others)
                Procedure time (min)*                                           80 (43-180)
                Number of catheter days (day)*                                  10 (9-13)
                Time to operation from procedure (day)*                         21 (12-34)
                Complications                                                   1 (7.7 %)
                  Procedure-related complications
                  hematoma formation                                            0
                Complications during chemotherapy
                  Hepatic arterial occlusion                                    0
                  Gastroduodenal ulcer                                          0
                  Cerebral infarction                                           0
                  Infection                                                     1
                Catheter dysfunction
                  Catheter dislodgement                                         0
                  Occlusion of catheter                                         0
               *Median with range


               liver function impairment and liver failure occurred after HAIC, and all patients underwent hepatectomy as
               expected [Table 3].


               Operative and perioperative outcome
               The operative outcomes and perioperative changes in liver function are presented in Tables 4 and 5. All
               patients with liver function impairment recovered. No adverse effect on liver function attributable to HAIC
               occurred after surgery. There was no difference in the operative outcomes of the 2 groups, and no hospital
               mortality was observed.

               Pathologic assessment
               The histopathologic findings of the resected livers are shown in Table 6. The histologic grade for patients in
               the treatment group after treatment was determined to be grade 0 for 3 patients (23%), grade 1a for 3 patients
               (23%), grade 1b for 3 patients (23%), grade 2a for 2 patients (15%), grade 2b for 1 patient (8%), and grade 3 for
               1 patient (8%).
   139   140   141   142   143   144   145   146   147   148   149